RHB Retail Research

Trading Stocks - Duopharma Biotech

rhboskres
Publish date: Mon, 05 Oct 2020, 12:08 PM
rhboskres
0 9,020
RHB Retail Research

Duopharma Biotech could be in the process of launching its next wave of an upleg. A positive bias may appear if it crosses above the MYR3.36 resistance with the subsequent resistance levels expected at MYR3.48 and MYR3.75. This bias should stay provided the MYR3.30 continues to hold

Source: RHB Securities Research - 5 Oct 2020

Related Stocks
Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment